Recently expert from Brigham and Women’s Hospital announce the result of a four gene expression ratio test from person who potentially differentiated mesothelioma in a period long time and from person who potentially differentiated mesothelioma in shorter time.
The study, published in a document entitled "The four gene expression ratio test of survival for patients work for Mesothelioma Surgery" in the Journal of the National Cancer Institute. The study concluded the gene ratio test malignant pleural mesothelioma patients "have a strong technical merit, and analysis of results." Effects noted in the Journal of the National Cancer Institute's Web site is a "gene ratio test should be further evaluated based on specimens collected patients prior to clinical intervention in order to determine whether its results can be incorporated into decision-making about the treatment of the patient."
